Clinical trial · Observational
Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments
Patient and Physician Preferences for Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer Treatments
NCT06448793CI-TRIAL-00120505completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to investigate the perspectives and preferences of patients and healthcare professionals (medical oncologists, pneumologists, thoracic surgeons) regarding treatment options in the resectable non-small cell lung cancer (NSCLC) setting
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-small Cell Lung Cancer (NSCLC) | Lung Non-Small Cell Carcinoma | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Approved Non-small Cell Lung Cancer (NSCLC) therapies | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Patients with a diagnosis of resectable non-small cell lung cancer (NSCLC)
- interventionNames
- Drug: Approved Non-small Cell Lung Cancer (NSCLC) therapies
- label
- Physicians currently treating resectable non-small cell lung cancer (NSCLC) patients
- interventionNames
- Drug: Approved Non-small Cell Lung Cancer (NSCLC) therapies
Primary outcomes (3)
- measure
- Responses to qualitative interview questions
- timeFrame
- Day 1
- description
- Interview questions designed to gather insights into diagnosis, symptoms, current treatments, perspectives on treatment features and test for mock preferences tasks. The interview will take 15 minutes to complete.
- measure
- Patient sociodemographic
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: Patients * Aged ≥18 years at the time of enrollment in the study * Resident of the US, Germany, or Japan * Able to read, speak, and understand English, German or Japanese * Diagnosed with resectable phase II to IIIB non-small cell lung cancer (NSCLC) Physicians * Resident of the US, Germany, or Japan * Lung cancer-treating physician specialized in one of the following medical areas: oncology, pneumonology, thoracic surgery, or radiology * Treated at least three new patients with resectable NSCLC in the past year Exclusion Criteria: Patients * Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment) * Being diagnosed with another malignancy alongside NSCLC * Not willing to be audio-recorded during the interview Physicians * Appears to have sensory and/or cognitive impairment(s) that could interfere with their ability to provide online and/or verbal consent, or complete any other interview activities (based on screener judgment) * Not willing to be audio-recorded during the interview
References
Publications (0)
Data not yet available
No reference posted for this study.